Initially, there were reports of a decrease in ADAM10, but further studies reveal no significant link between ADAM10 levels and cognitive symptoms in AD patients, so it has been proposed that these changes might be due to the medications taken by patients [30]. The gene discussed is ADAM10; the disease is Alzheimer disease.